Nassim Usman's Insider Trades & SAST Disclosures
Nassim Usman's most recent trade in Gyre Therapeutics Inc was a trade of 3,452 Common Stock done at an average price of $6.9 . Disclosure was reported to the exchange on June 28, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nassim Usman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gyre Therapeutics Inc | Nassim Usman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.93 per share. | 28 Jun 2024 | 3,452 | 5,088 | - | 6.9 | 23,922 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 3,452 | 278,200 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Nassim Usman | Director | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 28 Jun 2024 | 3,452 | 1,636 | - | 12.0 | 41,438 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.93 per share. | 01 May 2024 | 20,000 | 21,636 | - | 6.9 | 138,600 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 20,000 | 281,652 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Nassim Usman | Director | Sale of securities on an exchange or to another person at price $ 13.86 per share. | 01 May 2024 | 14,900 | 6,736 | - | 13.9 | 206,514 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Sale of securities on an exchange or to another person at price $ 14.90 per share. | 01 May 2024 | 5,000 | 1,736 | - | 14.9 | 74,500 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Sale of securities on an exchange or to another person at price $ 15.63 per share. | 01 May 2024 | 100 | 1,636 | - | 15.6 | 1,563 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.93 per share. | 01 Apr 2024 | 20,000 | 21,636 | - | 6.9 | 138,600 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 20,000 | 301,652 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Nassim Usman | Director | Sale of securities on an exchange or to another person at price $ 16.15 per share. | 01 Apr 2024 | 20,000 | 1,636 | - | 16.2 | 323,000 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.93 per share. | 15 Mar 2024 | 20,000 | 21,636 | - | 6.9 | 138,600 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Sale of securities on an exchange or to another person at price $ 17.26 per share. | 15 Mar 2024 | 20,000 | 1,636 | - | 17.3 | 345,200 | Common Stock |
| Gyre Therapeutics Inc | Nassim Usman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 20,000 | 321,652 | - | - | Stock Option (Right to Buy) | |
| Catalyst Biosciences Inc | Nassim Usman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 09 Aug 2022 | 3,250 | 24,541 (0%) | 0% | 0.5 | 1,528 | Common Stock |
| Catalyst Biosciences Inc | Nassim Usman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.46 per share. | 09 Feb 2022 | 3,250 | 21,291 (0%) | 0% | 0.5 | 1,495 | Common Stock |
| Catalyst Biosciences Inc | Nassim Usman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.62 per share. | 09 Aug 2021 | 867 | 18,041 (0%) | 0% | 3.6 | 3,139 | Common Stock |
| Catalyst Biosciences Inc | Nassim Usman | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. | 05 Apr 2021 | 5,000 | 17,174 (0%) | 0% | 4.6 | 23,150 | Common Stock |
| Catalyst Biosciences Inc | Nassim Usman | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 5,000 | 259,783 | - | - | Stock Option (Right to Buy) | |
| Catalyst Biosciences Inc | Nassim Usman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 4.81 per share. | 09 Feb 2021 | 582 | 12,174 (0%) | 0% | 4.8 | 2,799 | Common Stock |
| Catalyst Biosciences Inc | Nassim Usman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
| Catalyst Biosciences Inc | Nassim Usman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 4.81 per share. | 10 Aug 2020 | 582 | 11,592 (0%) | 0% | 4.8 | 2,799 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges